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What is Genomics? 
“Book of Life” - NY Times (2001) 
“Code of Life” – PBS (2002) 
“Map of Life” – Science World (1999) 
“Blueprint of Humanity” - BBC (2000) 
“Instruction Set” – Bob Waterston (2003) 
“Evolution’s Notebook” – Eric Lander (2002) 
 

Cost of 1Mb of DNA sequencing 
Sboner et al. Genome Biology 2011 12:125 
What is Personalized Medicine? 
“molecules measured in a patient’s lab tests 
can inform decisions about preventing or 
treating diseases” 
http://venturebeat.com 
Central Dogma 
http://www.rsc.org 
Proteins in human disease 
What do we now know about a typical human 
genome? 
• Nearly ALL genes have 
alternative isoforms 
 
• 65-80% of the genome is 
transcribed 
 
• ENCODE claims 80% of genome 
has some function 
 
COMPARE TWO INDIVIDUALS: 
• 99.9% identical 
 
• ~3 million variations (single 
nucleotide variations, 
insertions, deletions, copy 
number variations) 
 
http://www.technologyreview.com/featuredstory/422140/the-human-genome-a-decade-later/ 
Highly recommended reading:  
“We Gained Hope.” The Story of Lilly Grossman’s Genome 
National Geographic’s Blog  
“PHENOMENA: Not exactly rocket science” 
Posted:  Monday March 11, 2013 
http://phenomena.nationalgeographic.com/2013/03/11/we-gained-hope-the-story-of-lilly-grossmans-genome/ 
A cool sequencing success story! 

What makes us more than a worm? 
John Mattick 
What makes us more than a worm? 
S Djebali et al. Nature 489 101-108 (2012) 
We are more than just proteins 
DNA 
Protein coding gene 
Most disease associations are NOT to 
protein coding regions 
Schaub M A et al. Genome Res. 2012;22:1748-1759 
The Dowell Laboratory 
Studying Individual Differences 
“Nothing in biology makes sense 
except in the light of evolution.” 
 
--Theodosius Dobzhansky 
B 
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Case I: Alcohol 
Tolerance 
Recombinant 
Inbred Mice: 
LXS strains 

Overall sequencing strategy 
Single mouse liver Genomic DNA 
Illumina paired- 
end library 
(~300 bp) 
Illumina mate- 
pair library          
(~4 kb) 
Illumina mate- 
pair library      
(~10 kb) 
SNP/short 
indel calling 
(mapping) 
Illumina Hi-Seq      
2x100bp 
Structural variant 
(mapping, de novo assembly,??)  
Sequencing Data (Hi-Seq 2x100bp) 
8 lanes 
ILS ISS 
Total read pairs 427,367,178 439,844,784 
Total bases 85,473,435,600 87,968,956,800 
Avg Coverage (mm9) 31.3 X 32.3 X 
Variation compared to mm9 
BWA both bowtie total 
ILS 1,250,824 5,261,670 539,884 7,052,378 
ISS 934,491 4,644,440 524,765 6,103,696 
# Variants Percent 
Total Variants  9,289,436 100% 
snp128 4,547,533 49.0% 
indels 1,994,199 21.4% 
Identification of LXS Markers 
9,289,436 
 
6,406,493 
3,537,009 
Removal of variants common to 
both strains 
Removal of ambiguous markers 
between bwa and bowtie 
Total variants: 
Potential variants: 
High quality: 
1 marker every ~760 base pairs 
Breakdown of marker by refseq 
intergenic
intron
5'-UTR
cds
3'-UTR
2,229,652 
1,257,470 
5’-UTR: 4,041 
CDS: 25,506 
3’-UTR: 24,283 
Are protein-altering variations enriched in QTL 
hotspots? 
p = 0.1328 
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• 3655 genes with protein sequence differences between ILS and ISS 
 
• 265 genes with aa differences found in QTL regions 
 
• 10,000 randomly samples genome with intervals the same size of QTL regions 
# genes found in randomly sampled sequence  
265 
The next step: eQTLs 
Down Syndrome 
Chris Jepson Photography 
Case II: Increased copy number 
Polyploidy and Aneuploidy  
occur frequently in nature 
Rapid evolution of yeast tetraploids in raffinose 
Diploid (2N) 
Tetraploid (4N) 
Haploid (1N) 
pGAL YFP tADH 
CFP tADH pGAL 
OR 
pGAL YFP tADH 
CFP tADH pGAL 
OR 
pGAL YFP tADH 
CFP tADH pGAL 
pGAL YFP tADH 
pGAL YFP tADH 
CFP tADH pGAL 
CFP tADH pGAL 
pGAL YFP tADH 
CFP tADH pGAL 
OR 
pGAL YFP tADH 
CFP tADH pGAL 
Flow Cytometry 
#YFP 
#CFP 
Passage every 24 hours, 
   Flow every 24 hours  
Endpoint at 240  generations Mix 1:1  
CFP:YFP ancestors 
In vitro evolution experimental outline 
Beneficial 
 mutation 
Rapid evolution of yeast tetraploids in raffinose 
Diploid (2N) 
Tetraploid (4N) 
Haploid (1N) 
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Chromosome 
Aneuploid 4Ne Clones at Gen250 
(n=20) 
Gain
Loss
* 
Recurrent aneuploidies occurred during 4N adaptation 
* Mann-Whitney  pval < 0.00001, * K-S   pval < 0.00113 
   
Ploidy at Gen250
1N 2N 4N
0
1C
2C
4C
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2N and 4N clones acquire genetic mutations 
during adaptation to raffinose 
DFG5 
promoter 
HXT6/7  
LTE1 
SNF3 
Syn. SNPs 
Non-Syn. SNPs 
Nonsense 
Other SNPs 
CNV 
Our work and others suggest the mutation rate is generally higher in cells of higher ploidy. 
2N 
SNG1 
DIN7 
PGU1 
SPG5 
SCO2 promoter 
HXT6/7  PDC2 
VTC2 
YGR266W 
TFB4 
EFM1 
YSP3 
HXT6/7 
Chr XIII 
Chr XIV 
 Seg. of Chr IV 
  
SPT15 
YTA7 
TOR2 
Chr IX, Chr XIII, 
Chr XIV 
PBP1 
FAS1 
SPL2 promoter 
HXT6/7 
Chr XIII 
Chr XII 
3N 4N 
Still far from “causality” 
Evidence for dominant beneficial mutations 
Vtc2 (vacuolar transport 
chaperone) mutant data – 
suggests 4N cells also acquire 
neutral to slightly deleterious 
mutations 
• No fitness cost in rich media. 
 
 
• Fitness effect similar to HXT6/7 
amplification. 
 HXT6/7 
Expansion 
SNF3/MTH1 
Identify at least two pathways to 
adaptation! 
?? 
Yeast teach us a lot about aneuploidy 
The next step: Down sequencing 
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